1-6 of 6
Authors: Renee Ackley
Sort by
Journal Article
311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
jason M Pogue and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.101, https://doi.org/10.1093/ofid/ofae631.101
Published: 29 January 2025
Journal Article
312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
Michael P Veve and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.102, https://doi.org/10.1093/ofid/ofae631.102
Published: 29 January 2025
Journal Article
1109. A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)
Ryan K Shields and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.082, https://doi.org/10.1093/ofid/ofad500.082
Published: 27 November 2023
Journal Article
1826. Comparative Use of Vancomycin versus Ampicillin for Blood Stream Infections Caused by Ampicillin-susceptible Enterococcus faecalis
Michaele Phan and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1456, https://doi.org/10.1093/ofid/ofac492.1456
Published: 15 December 2022
Journal Article
1621. Novel Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis Caused by Carbapenem-resistant Enterobacterales
Bliss Green and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S803, https://doi.org/10.1093/ofid/ofaa439.1801
Published: 31 December 2020
Journal Article
662. Recurrence of Infection and Emergence of Drug Resistance After Treatment with Meropenem/Vaborbactam Compared with Ceftazidime/Avibactam in Carbapenem-Resistant Enterobacteriaceae Infections
Renee Ackley and others
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S303, https://doi.org/10.1093/ofid/ofz360.730
Published: 23 October 2019
Advertisement
Advertisement